CG Invites

We strive to be a global biopharma leader whose mission is

to develop innovative, life-changing medicine

Publication

NOTICE
Kim, Y.D. et al. HDAC Inhibitor, CG-745, enhances the anti-cancer effect of anti-PD-1 immune checkpoint inhibitor by modulation of the immune microenvironment. J. Cancer. 11, 4059-4072 (2020)
2021
06.21
2021-06-21
첨부파일















 

LIST